Complete remission through icotinib treatment in Non-small cell lung cancer epidermal growth factor receptor mutation patient with brain metastasis: A case report

Por Wang, Tao, Wang, Ruimin, Dong, Zhouhuan, Liang, Naichao, Chang, Ping
Publicado no Open Med (Wars) (2016)

Patients with advanced non-small cell lung cancer with EGFR mutations in addition to complex mutations treated with osimertinib have a poor clinical outcome: A real-world data anal...

Por Chang, Nijia, Duan, Jingjing, Wang, Lingxiong, Dong, Zhouhuan, Liu, Zhefeng
Publicado no Oncol Lett (2020)

Effects of icotinib on early-stage non-small-cell lung cancer as neoadjuvant treatment with different epidermal growth factor receptor phenotypes

Por Wang, Tao, Liu, Yang, Zhou, Bin, Wang, Zhi, Liang, Naichao, Zhang, Yundong, Dong, Zhouhuan, Li, Jie
Publicado no Onco Targets Ther (2016)

Somatic mutation profiling and HER2 status in KRAS-positive Chinese colorectal cancer patients

Por Dong, Zhouhuan, Kong, Linghong, Wan, Zhiyi, Zhu, Fengwei, Zhong, Mei, Lv, Yali, Zhao, Po, Shi, Huaiyin
Publicado no Sci Rep (2019)

GLI1 activation is a key mechanism of erlotinib resistance in human non-small cell lung cancer

Por Dong, Zhouhuan, Wang, Yun, Ding, Vivianne, Yan, Xiang, Lv, Yali, Zhong, Mei, Zhu, Fengwei, Zhao, Po, He, Charlotte, Ding, Feng, Shi, Huaiyin
Publicado no Oncol Lett (2020)

The different expression of glycogen phosphorylases in renal clear cell renal carcinoma and chromophobe renal carcinoma

Por Lu, Yang, Luo, Guangda, Zhu, Songbiao, Wang, Xu, Chen, Yuling, Dong, ZhouHuan, Wang, Shiyu, Ma, Jie, Deng, Haiteng, Wu, Di, Dong, Jun
Publicado no Clin Proteomics (2020)

Catalog of Lung Cancer Gene Mutations Among Chinese Patients

Por Xue, Xinying, Asuquo, Idorenyin, Hong, Lei, Gao, Jie, Dong, Zhouhuan, Pang, Li, Jiang, Tianjiao, Meng, Mingming, Fan, Jingbo, Wen, Jiaxin, Deng, Hui, Zang, Xuelei, Ma, Xidong, Guo, Rui, Qin, Chong, Meng, Yao, Ma, Heji, Han, Jun, Wang, Haijiao, Xue, Zhiqiang, Zhao, Dahai, Lin, Dongliang, Pan, Lei
Publicado no Front Oncol (2020)